France Drugs Addiction Market Analysis

France Drugs Addiction Market Analysis


$ 3999

France Drugs Addiction Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drug addiction market is driven by rising substance usage, increased awareness and public health campaigns, breakthroughs in treatment methods, government initiatives and legislation, and the high frequency of co-occurring mental health issues. Indivior PLC, Alkermes plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Orexo AB, Mylan N.V., Glenmark Pharmaceuticals, Accord Healthcare Ltd., and Camurus AB are global players in the Drug Addiction Market.

ID: IN10FRPH273 CATEGORY: Pharmaceuticals GEOGRAPHY: France AUTHOR: Dr. Medha Sansanwal

Buy Now

France Drugs Addiction Market Analysis Summary

France Drugs Addiction Market is valued at around $490.2 Mn in 2022 and is projected to reach $1113.3 Mn by 2030, exhibiting a CAGR of 10.8% during the forecast period 2023-2030.

The drug addiction market consists of treatment centers, pharmaceuticals, behavioral therapies, support groups, rehabilitation services, prevention programs, research and development, and government agencies. These components work together to address addiction, provide treatment, support recovery, and implement preventive measures. Increasing substance abuse, growing awareness and public health initiatives, advancements in treatment methods, government initiatives and policies, and the high prevalence of co-occurring mental health disorders are the drivers of the drug addiction market. Global Players in the Drug Addiction Market are Indivior PLC, Alkermes plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Orexo AB, Mylan N.V., Glenmark Pharmaceuticals, Accord Healthcare Ltd., and Camurus AB are global players in the Drug Addiction Market.

Market Dynamics

Market Growth Drivers

  1. Increasing substance abuse: A primary driver for the drug addiction industry is the increased prevalence of substance misuse, which includes opioids, alcohol, and illicit drugs. As a result, there is a greater demand for addiction treatment and recovery services
  2. Raising awareness and promoting public health initiatives: Addiction treatment and intervention programs are in high demand due to increased awareness of the effects of substance addiction and public health initiatives
  3. Treatment technique advancements: Market expansion is being driven by advancements in pharmacological interventions, behavioral therapies, and novel therapeutic techniques such as medication-assisted therapy (MAT)
  4. Initiatives and policies of the government: Government attempts to combat drug addiction, such as increased funding for treatment programs, harm reduction methods, and legislation reforms, are critical to market growth
  5. Co-occurring mental health disorders: The high prevalence of co-occurring mental health disorders with substance abuse fuels the demand for integrated treatment approaches, driving the growth of the drug addiction market

Market Restraints

  1. Stigma and social barriers: Addiction stigma and low social acceptance might prevent people from seeking treatment, limiting market growth
  2. Inadequate access to treatment: A lack of availability and accessibility of addiction treatment services, particularly in rural and low-resource settings, might limit market growth
  3. Expensive treatment: The expense of addiction treatment, which includes therapy, drugs, and recovery programs, can be too expensive for certain people, limiting market growth
  4. Regulatory issues: Market dynamics may be influenced by stringent laws and compliance requirements for addiction treatment facilities and pharmaceuticals

Competitive Landscape

Key Players

  • Indivior PLC
  • Alkermes plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals
  • Orexo AB
  • Mylan N.V.
  • Glenmark Pharmaceuticals
  • Accord Healthcare Ltd.
  • Camurus AB

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

France Drugs Addiction Market Segmentation

By Type

  • Opioid Addiction
  • Benzodiazepine Addiction
  • Barbiturate Addiction
  • Others

By Treatment

  • Therapy
  • Medication
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up